Live feed
Filing
SC 13D/A
SC 13D/A0001193125-21-299063·ARMISTICE CAPITAL, LLC
Schedule 13D ownership disclosure
Avalo Therapeutics, Inc.
Security class unavailable · CUSIP: 05338F108
Event date: 2021-10-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 43.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-299063
- Form type
- SC 13D/A
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Oct 15, 2021
- Reporting period
- Oct 14, 2021
- Description
- Schedule 13D beneficial ownership